Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of molecular diagnostics products and services that are used to diagnose human diseases, screen donated human blood, ensure transplant compatibility, and aid biomedical research. Gen-Probe has nearly three decades of molecular diagnostics expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing molecular assays and systems that help safeguard the blood supply.

February 15, 2012 -FDA Approves Gen-Probe's PROGENSA® PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies... more
February 13, 2012 -Gen-Probe Reports Financial Results for the Fourth Quarter of 2011... more

Webcast - Q4 2011 Gen-Probe Incorporated Earnings Conference Call (Live) 02/13/12 at 4:30 p.m. ET... listen
Webcast - Gen-Probe Inc at Leerink Swann Global Healthcare Conference Wednesday, February 15, 2012 at 2 p.m. ET... listen














